Pharmaceuticals

Ticagrelor Market Forecast: How Big Will It Be by 2030?

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the ticagrelor market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Ticagrelor Market between 2026 and 2030?

The ticagrelor market has experienced significant expansion over the past few years. Forecasts indicate it will expand from $1.93 billion in 2025 to reach $2.08 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.6%. Historically, this growth can be attributed to several factors, including the limited availability of antiplatelet therapies, the growing cardiovascular disease prevalence, the expansion of hospital pharmacy networks, increasing clinical trials for cardiovascular drugs, and rising awareness of heart attack and stroke risks.

The ticagrelor market size is anticipated to demonstrate substantial expansion in the coming years, reaching $2.75 billion by 2030, with a compound annual growth rate (CAGR) of 7.3%. This growth during the forecast period can be attributed to several factors, such as the introduction of extended-release ticagrelor tablets, the wider distribution through retail and online pharmacies, the increasing adoption of personalized cardiovascular treatment, a rise in government initiatives for cardiovascular disease prevention, and the integration with digital health monitoring systems. Prominent trends expected in this period include the rising utilization of ticagrelor in acute coronary syndrome management, a growing preference for oral antiplatelet therapy over injectable options, the expansion of hospital and ambulatory cardiology services, increased awareness regarding stroke and myocardial infarction prevention, and the continued development of extended-release ticagrelor formulations.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24726&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Ticagrelor Market?

The expanding occurrence of cardiovascular diseases is projected to drive the future expansion of the ticagrelor market. Cardiovascular diseases encompass various conditions impacting the heart and blood vessels, such as coronary heart disease, heart failure, stroke, and high blood pressure. This rise in cardiovascular diseases is largely linked to unhealthy dietary habits, where excessive intake of saturated fats, trans fats, added sugars, and sodium leads to hypertension, obesity, and heightened cholesterol, all significant precursors to cardiac issues. Ticagrelor aids in managing cardiovascular ailments by inhibiting platelet clumping, thereby lowering the likelihood of blood clot formation. This medication enhances patient recovery and prognosis by decreasing the probability of heart attacks and strokes, particularly for vulnerable patients. An example highlighting this trend is seen in January 2024, when the American Heart Association, a US-based non-profit organization, reported an increase in the age-adjusted death rate from cardiovascular disease to 233.3 per 100,000 in 2024, marking a 4.0% rise from 224.4 per 100,000 in 2023. Consequently, the growing incidence of cardiovascular diseases is a key factor propelling the expansion of the ticagrelor market.

What Segments Are Included Within The Ticagrelor Market?

The ticagrelor market covered in this report is segmented –

1) By Type: 90 mg Tablet, 60 mg Tablet

2) By Drug Class: Antiplatelet Agents, Antithrombotic Agents

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By Application: Acute Coronary Syndrome, Myocardial Infarction, Stroke Prevention, Other Applications

5) By End User: Hospitals And Clinics, Ambulatory Centers, Other End Users

What Industry Trends Are Transforming The Ticagrelor Market?

Leading companies active in the ticagrelor market are concentrating on obtaining regulatory clearances to broaden product applications, increase market reach, and strengthen their competitive position. Regulatory approvals represent the official permission granted by government bodies to commercialize and sell a product, ensuring it complies with safety, efficacy, and quality criteria. For example, in May 2025, Alembic Pharmaceuticals Ltd., an India-based pharmaceutical enterprise, received an abbreviated new drug application (ANDA) from the US Food & Drug Administration (USFDA) for its generic ticagrelor tablets 90 mg and tentative approval for the 60 mg strength. These tablets are utilized to decrease the risk of cardiovascular events and function by inhibiting platelet aggregation, thereby preventing the formation of blood clots.

Who Are The Prominent Global Companies Shaping The Ticagrelor Market Landscape?

Major companies operating in the ticagrelor market are AstraZeneca PLC, Merck KGaA, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Limited, Cadila Pharmaceuticals Limited, Alkem Laboratories, Alembic Pharmaceuticals Limited, CCL Pharmaceuticals, Neuland Laboratories, Jiangxi Synergy Pharmaceutical Co. Ltd., Leeford Healthcare Limited, Scimplify, JAMP Pharma Corporation, Actoverco Pharmaceutical Company, CTX Lifesciences Private Limited, DM Pharma, Hema Pharmaceuticals Pvt. Ltd., Chia-Tai Tianqing Pharmaceutical Group Co. Ltd., Biophar Lifesciences Pvt. Ltd., PhaseBio Pharmaceuticals Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/ticagrelor-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Ticagrelor Market?

North America was the largest region in the ticagrelor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ticagrelor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Ticagrelor Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24726&type=smp

Browse Through More Reports Similar to the Global Ticagrelor Market 2026, By The Business Research Company

Induced Pluripotent Stem Cell Market Report 2026

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

Cell Based Assays Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Stem Cell Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795